Company Overview of Ondek Pty Ltd.
Ondek Pty Ltd., a biotechnology company, develops and commercializes a drug and vaccine delivery platform based on the use of genetically modified Helicobacter pylori bacteria. It develops Helicobacter pylori Platform Technology (HPPT), a drug and vaccine delivery vehicle, which utilizes the characteristics of a genetically modified Helicobacter pylori bacterium to deliver therapeutics to the patient, including vaccines or other biologicals, as well as for chronic diseases, such as obesity, hypertension, and diabetes. The company also develops a human influenza vaccine. Ondek Pty Ltd. was founded in 2005 and is based in Rushcutters Bay, Australia.
19a Boundary Street
Rushcutters Bay, NSW 2011
Founded in 2005
61 2 9332 0600
61 2 9332 2862
Key Executives for Ondek Pty Ltd.
Similar Private Companies By Industry
|AbRegen Pty Ltd.||Asia|
|Advanced Wound Care Pty Ltd.||Asia|
|Agriliance Pty Ltd.||Asia|
|AION Diagnostics Limited||Asia|
|Aquaceutics Pty Ltd||Asia|
Recent Private Companies Transactions
June 30, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ondek Pty Ltd., please visit www.ondek.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.